Vicarious Surgical (RBOT) Competitors $6.70 +0.43 (+6.78%) Closing price 03:58 PM EasternExtended Trading$6.68 -0.01 (-0.15%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RBOT vs. MBOT, AVR, LAKE, RCEL, LNSR, SPAI, LUCD, INO, HYPR, and PDEXShould you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Microbot Medical (MBOT), Anteris Technologies Global (AVR), Lakeland Industries (LAKE), Avita Medical (RCEL), LENSAR (LNSR), Safe Pro Group (SPAI), Lucid Diagnostics (LUCD), Inovio Pharmaceuticals (INO), Hyperfine (HYPR), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry. Vicarious Surgical vs. Its Competitors Microbot Medical Anteris Technologies Global Lakeland Industries Avita Medical LENSAR Safe Pro Group Lucid Diagnostics Inovio Pharmaceuticals Hyperfine Pro-Dex Microbot Medical (NASDAQ:MBOT) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Which has higher earnings and valuation, MBOT or RBOT? Microbot Medical is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$11.44M-$0.58-5.03Vicarious SurgicalN/AN/A-$63.22M-$10.09-0.66 Is MBOT or RBOT more profitable? Microbot Medical's return on equity of -76.27% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -76.27% -67.54% Vicarious Surgical N/A -148.14%-98.07% Do analysts rate MBOT or RBOT? Microbot Medical presently has a consensus target price of $12.00, indicating a potential upside of 310.96%. Vicarious Surgical has a consensus target price of $7.00, indicating a potential upside of 4.56%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than Vicarious Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Vicarious Surgical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Do institutionals and insiders believe in MBOT or RBOT? 16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by company insiders. Comparatively, 12.0% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor MBOT or RBOT? In the previous week, Microbot Medical had 6 more articles in the media than Vicarious Surgical. MarketBeat recorded 7 mentions for Microbot Medical and 1 mentions for Vicarious Surgical. Microbot Medical's average media sentiment score of 0.58 beat Vicarious Surgical's score of 0.15 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 0 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vicarious Surgical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, MBOT or RBOT? Microbot Medical has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. SummaryMicrobot Medical beats Vicarious Surgical on 9 of the 13 factors compared between the two stocks. Get Vicarious Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RBOT vs. The Competition Export to ExcelMetricVicarious SurgicalMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$37.19M$7.05B$6.11B$21.91BDividend YieldN/A1.18%5.73%3.62%P/E Ratio-0.6626.2685.3630.12Price / SalesN/A27.42606.8766.91Price / CashN/A21.7037.4624.26Price / Book0.855.2112.424.70Net Income-$63.22M$178.09M$3.32B$1.01B7 Day Performance-5.97%-2.03%1.01%-0.44%1 Month Performance14.44%5.87%10.75%1.45%1 Year Performance-24.73%6.15%76.20%15.02% Vicarious Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RBOTVicarious Surgical1.0853 of 5 stars$6.70+6.8%$7.00+4.6%-9.7%$37.19MN/A-0.66210MBOTMicrobot Medical1.7086 of 5 stars$3.22+4.9%$12.00+272.7%+199.6%$162.08MN/A-5.5520News CoverageAnalyst ForecastGap UpAVRAnteris Technologies Global1.9315 of 5 stars$4.40+2.1%$16.50+275.0%N/A$155.43M$2.70M0.00138News CoverageGap UpLAKELakeland Industries4.7813 of 5 stars$15.49+0.4%$25.00+61.4%-16.8%$147.68M$167.21M-5.652,100RCELAvita Medical2.352 of 5 stars$5.52-0.4%$11.60+110.1%-49.4%$147.47M$64.25M-2.80130LNSRLENSAR2.0432 of 5 stars$12.08-0.9%$15.00+24.2%+116.6%$145.49M$53.49M-2.87110News CoverageSPAISafe Pro Group3.1825 of 5 stars$7.48-0.3%$10.50+40.4%+197.4%$141.10M$2.17M-9.3511Gap UpLUCDLucid Diagnostics3.0684 of 5 stars$1.03-1.0%$3.70+259.2%+52.7%$138.82M$4.35M-0.8770News CoverageAnalyst UpgradeINOInovio Pharmaceuticals3.7994 of 5 stars$2.41-0.8%$8.80+265.1%-57.2%$129.14M$220K-0.92320HYPRHyperfine1.0736 of 5 stars$1.52+2.7%$1.28-15.6%+106.2%$116.30M$12.89M-2.92190News CoverageGap UpPDEXPro-Dex3.0576 of 5 stars$33.84-0.6%$56.00+65.5%-9.4%$111.01M$66.59M12.53140News Coverage Related Companies and Tools Related Companies MBOT Alternatives AVR Alternatives LAKE Alternatives RCEL Alternatives LNSR Alternatives SPAI Alternatives LUCD Alternatives INO Alternatives HYPR Alternatives PDEX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RBOT) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
